Concepedia

Lars A. Ormandy

LA

9

Publications

2.7K

Citations

9

H-Index

2004

Active since

Affiliations

Medizinische Hochschule Hannover(Current)

Center for Experimental and Clinical Infection Research

University of Göttingen

National Cancer Institute

National Institutes of Health

Lars A. Ormandy is an author at Medizinische Hochschule Hannover specializing in medicine, immunology, and immunotherapy.

Top concepts

Publications per year

2004–2012

9

Publications

9

A New Population of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Induces CD4+CD25+Foxp3+ T Cells

Bastian Hoechst, Lars A. Ormandy, Matthias Ballmaier et al. · Gastroenterology · 2008 · 775 citations · Full text

, , +8

Increased Populations of Regulatory T Cells in Peripheral Blood of Patients with Hepatocellular Carcinoma

Lars A. Ormandy, Tina Hillemann, Heiner Wedemeyer et al. · Cancer Research · 2005 · 638 citations · Full text

Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor #

Bastian Hoechst, Torsten Voigtlaender, Lars A. Ormandy et al. · Hepatology · 2009 · 624 citations · Full text

A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma

Tim F. Greten, Alejandro Forner, Firouzeh Korangy et al. · BMC Cancer · 2010 · 205 citations · Full text

Spontaneous Tumor-Specific Humoral and Cellular Immune Responses to NY-ESO-1 in Hepatocellular Carcinoma

Firouzeh Korangy, Lars A. Ormandy, Jörg S. Bleck et al. · Clinical Cancer Research · 2004 · 137 citations

Rows per page

1–5 of 9